Companies sponsors |
Menarini Stemline (selinexor) |
Others |
Department of Health and Social Care |
|
NHS England |
|
Welsh Government |
Patient carer groups |
Myeloma UK |
Professional groups |
Association of Cancer Physicians |
|
Cancer Research UK |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal College of Radiologists |
|
UK Myeloma Society |
Comparator companies |
AbbVie (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Advanz pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
AS Kalceks (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Aspen (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Aspire Pharma (bortezomib, dexamethasone) (confidentiality agreement not signed, not participating) |
|
Bristol Myers Squibb Pharmaceuticals (pomalidomide) (confidentiality agreement not signed, not participating) |
|
Celgene (pomalidomide) (confidentiality agreement not signed, not participating) |
|
Consilient Health (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Dr Reddy’s Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
GlaxoSmithKline (belantamab mafodotin) (confidentiality agreement signed, participating) |
|
Glenmark Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Hameln Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Hospira UK (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Janssen-Cilag (bortezomib) (confidentiality agreement signed, participating) |
|
Krka UK (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Martindale Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Medac GmbH (bortezomib) (confidentiality agreement not signed, not participating) |
|
MSN Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Mylan (bortezomib) (confidentiality agreement not signed, not participating) |
|
Novartis Pharmaceuticals (panobinostat) (confidentiality agreement not signed, not participating) |
|
Panpharma UK (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Pfizer (bortezomib) (confidentiality agreement not signed, not participating) |
|
Ranbaxy UK Limited a Sun Pharmaceutical Company (bortezomib) (confidentiality agreement not signed, not participating) |
|
Rosemont Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Sandoz (bortezomib) (confidentiality agreement not signed, not participating) |
|
Secura Bio (panobinostat) (confidentiality agreement not signed, not participating) |
|
Synchrony Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Thame Laboratories (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Thea Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Thornton and Ross (bortezomib) (confidentiality agreement not signed, not participating) |
|
Tillomed Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Wockhardt UK (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Zentiva (bortezomib) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare Products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Institute of Cancer Research |
|
National Institute for Health Research |